News

Find News

Filter articles

Showing 21 to 30 of 2458 results

English court claims jurisdiction in Unilever antibody dispute

UK03-04-2019

The English High Court will hear a patent dispute between a subsidiary of biopharmaceutical company Sanofi and British-Dutch consumer goods brand Unilever.

EPO president refers plant patentability decision for appeal

EU02-04-2019

European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

AstraZeneca and Daiichi Sankyo to develop new cancer treatment

EU, Japan, UK02-04-2019

Biopharmaceutical company AstraZeneca has entered into an agreement with Japanese pharmaceutical company Daiichi Sankyo to develop and commercialise trastuzumab deruxtecan, a potential new medicine for cancer treatment.

FTC rules Impax received illegal payments to block pain reliever generic

US01-04-2019

Pharmaceutical company Impax Laboratories engaged in illegal pay-for-delay settlements to stop a generic version of one of its medications from entering the market, the US Federal Trade Commission has ruled.

Fed Circuit backs Endo in Alice suit over oxymorphone patent

US29-03-2019

The US Court of Appeals for the Federal Circuit yesterday, March 28, overturned a district court decision and handed a victory to pharmaceutical companies Endo and Mallinckrodt.

Eli Lilly defeat shows one size does not fit all in obviousness test: lawyers

UK28-03-2019

The UK Supreme Court’s decision in Actavis v Eli Lilly confirms that a multi-factorial judgement should be used to determine whether an invention is obvious or not, lawyers have told WIPR.

Cancer Research UK forms immunotherapy alliance

UK28-03-2019

Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

UK27-03-2019

The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

Stanford sues Natera over transplant testing patents

US27-03-2019

Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.

GSK sues Chinese company over Advair Diskus TMs

US26-03-2019

Pharmaceutical company GSK has taken a Chinese company to court over its alleged “deliberate and unlawful campaign” to copy GSK’s trademarks.

Showing 21 to 30 of 2458 results

LSIPR